← Back to Search

Behavioural Intervention

PDM Alert for Postoperative Delirium

N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
65 years old Planned inpatient major surgery requiring inpatient stay ≥ 1 day
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Summary

This trial will test whether using a delirium risk indicator on paper or in electronic medical records can reduce the chances of developing delirium after surgery and decrease the risk of long-term cognitive decline and

Who is the study for?
This trial is for individuals who are at least 65 years old and scheduled for major inpatient surgery that requires staying in the hospital for one or more days. It's not suitable for those who don't meet these criteria.
What is being tested?
The study is testing a 'PDM Alert' system, which uses electronic medical records (EMR) data and artificial intelligence to predict the risk of postoperative delirium. Participants will receive this alert either on paper or through EMR to see if it affects delirium rates and long-term cognitive health.
What are the potential side effects?
Since this trial involves an alert system rather than medication, traditional side effects are not applicable. However, there may be indirect effects on patient care based on how healthcare providers respond to the delirium risk alerts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction in delirium incidence and severity
Secondary outcome measures
Patient Satisfaction
Provider Satisfaction
Reduction in the number of inpatient falls as well as the use of restraints, sedatives, and personal safety attendants

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: PDM AlertExperimental Treatment1 Intervention
PDM alert will be placed on subject's record
Group II: No PDM AlertPlacebo Group1 Intervention
No PDM alert will be placed on subject's record

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,943 Total Patients Enrolled
36 Trials studying Delirium
38,675 Patients Enrolled for Delirium
Indiana UniversityLead Sponsor
1,019 Previous Clinical Trials
1,114,155 Total Patients Enrolled
9 Trials studying Delirium
5,411 Patients Enrolled for Delirium
~40 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top